Lyotropic liquid crystal precursor as well as preparation method and application thereof

A technology of lyotropic liquid crystals and precursors, which is applied in the field of lyotropic liquid crystal precursors and their preparation, can solve the problems that drug therapy cannot effectively achieve the therapeutic purpose, lack of joint protection function, lack of joint cavity drug delivery system, etc., and achieve improved Joint protection function, improvement of treatment effect, effect of protecting structure and function

Active Publication Date: 2021-06-18
GUANGZHOU NEWORLD PHARMA CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are currently no effective treatments that can achieve the core therapeutic goal of preserving joint structure and function
The lack of joint protection function makes drug therapy unable t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lyotropic liquid crystal precursor as well as preparation method and application thereof
  • Lyotropic liquid crystal precursor as well as preparation method and application thereof
  • Lyotropic liquid crystal precursor as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Glyceryl monooleate (GMO) was melted in a water bath at 45°C at 1:9, 2:8, 3:7, 4:6, 5:5, 6:4, 7:3, 8:2, 9: The ratio of 1 (w / w) is uniformly mixed with N-methylpyrrolidone (NMP) respectively to obtain glycerol monooleate solutions with different concentrations;

[0055] Dispersing hyaluronic acid powder with a molecular weight of 50-100KDa in water to obtain hyaluronic acid particles with a water content of 10%;

[0056] The hyaluronic acid particles were uniformly dispersed in the glycerol monooleate solution at a concentration of 3.4 mg / mL to obtain precursor solutions with different formulation compositions.

[0057] The above precursor solution was mixed with water at a ratio of 1:9, 2:8, 3:7, 4:6, 5:5, 6:4, 7:3, 8:2, 9:1 (w / w) Mix the mixture evenly and place it at room temperature for 3 days. Observing the above sample with a hot stage polarizing microscope, photographing its polarized texture, identifying the crystal phase of the liquid crystal according to

Embodiment 2

[0060] Glyceryl monooleate (GMO) was melted in a water bath at 45°C and mixed uniformly with N-methylpyrrolidone (NMP) at a ratio of 8:2 (w / w) to obtain a glyceryl monooleate solution;

[0061] Dispersing hyaluronic acid powder with a molecular weight of 50-100KDa in water to obtain hyaluronic acid particles with a water content of 10%;

[0062] The hyaluronic acid particles were uniformly dispersed in the glycerol monooleate solution at a concentration of 3.4 mg / mL to obtain a lyotropic liquid crystal precursor solution.

[0063] The ability of the lyotropic liquid crystal precursor solution in this embodiment to form a gel when it meets water is evaluated by using a Test-Tube experiment. Add 2mL of precursor solution into a 10mL vial, observe the morphological characteristics of the obtained precursor solution in upright and inverted states, then add deionized water drop by drop to the precursor solution until the precursor solution just forms a gel , and then observe the

Embodiment 3

[0066] 1. Glyceryl monooleate (GMO) was melted in a water bath at 45°C, and then mixed uniformly with N-methylpyrrolidone (NMP) at a ratio of 6:4, 7:3, and 8:2 (w / w) to obtain Different concentrations of glyceryl monooleate solution (recipe composition see Table 1).

[0067] 2. Glyceryl monooleate (GMO) was melted in a water bath at 45°C and mixed evenly with N-methylpyrrolidone (NMP) at a ratio of 8:2 (w / w) to obtain a glyceryl monooleate solution; the molecular weight The hyaluronic acid powder that is 50-100KDa is dispersed in water, obtains the hyaluronic acid particle (HA particle) that water content is respectively 5%, 10% and 15%; The concentration is uniformly dispersed in the glycerol monooleate solution to obtain a lyotropic liquid crystal precursor solution (refer to Table 1 for the composition of the recipe).

[0068] Viscosity test: using Kinexus lab + The viscosity test procedure of the rotational rheometer measures the viscosity change of the liquid crystal p

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Diameteraaaaaaaaaa
Water contentaaaaaaaaaa
Molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention relates to a lyotropic liquid crystal precursor as well as a preparation method and application thereof. The lyotropic liquid crystal precursor is prepared from the following raw materials: a lipid matrix, a cosolvent, and aqueous hyaluronic acid particles; the mass ratio of the lipid matrix to the cosolvent is (1.5-6) : 1; the concentration of the aqueous hyaluronic acid particles in the lyotropic liquid crystal precursor is 2-5 mg/mL; and the lipid matrix is at least one selected from glyceryl monooleate, phytantriol, phospholipid, glyceryl monopalmitoleate and linoleic acid monoglyceride. The lyotropic liquid crystal precursor can be used as a carrier for delivering drugs in an articular cavity, and used for delivering drugs for treating osteoarthritis or repairing cartilage injury. Being used as a carrier for delivering drugs in the articular cavity, the lyotropic liquid crystal precursor has the advantages of being capable of buffering joint oscillation, absorbing joint stress, protecting structure and function of articular cartilage, slowly releasing drugs and the like, thereby remarkably improving treatment effects of the drugs.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner GUANGZHOU NEWORLD PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products